cystectomies were performed on patients with a known history of bladder cancer treated with both chemotherapy and radiation therapy. Demographics, pathology, complications, and outcomes data were collected by chart review. The Kaplan-Meier method was used to calculate metastasis-free and overall survival. The log-rank test was used to compare survival curves.
. Median Charlson comorbidity index was 6. 10 of 16 cystectomies were started via a minimally invasive approach (8 robotic, 2 laparoscopic). One robotic and one laparoscopic cystectomy was converted to open. In patients who had lymphadenectomy, median nodal yield was 13 . 11 patients had ileal conduit urinary diversion and 5 had continent diversion (4 Indiana pouch, 1 Studer neobladder). Median estimated blood loss was 500 mL and 9 patients required intraoperative blood transfusion. At 90 days after surgery, 5 patients developed a Clavien-Dindo complication grade !3 (1 mortality). Median hospital stay was 11 days. Five patients developed distant metastasis at a median of 13.3 months after surgery. Median overall survival was 31.4 months (95% CI 4.2-96.8). Patients who had cisplatin-based chemotherapy experienced longer overall survival than those who had non cisplatinbased chemotherapy (67.9 vs. 16.3 months, p[0.03) .
CONCLUSIONS: Although salvage cystectomy is a morbid surgery, a subset of patients experienced significant metastasis-free and overall survival. Robotic approaches and continent urinary diversions are feasible. Additional study is needed to guide management in this rarely studied patient population.
Source of Funding: None

MP05-20 INCREASING ADIPOSITY IN BLADDER CANCER SURVIVORS: DOES DIET MATTER?
Yingqi Wang*, Singapore, Singapore; Andrew Chang, Wei Phin Tan, Joseph Fantony, Gregory Barton, Paul Wischmeyer, Rajan Gupta, Brant Inman, Durham, NC INTRODUCTION AND OBJECTIVES: Increasing adiposity has been shown to adversely affect bladder cancer (BC) outcomes, but why adiposity changes in some BC survivors but not others is currently unknown. We study the role of dietary factors affecting adiposity in BC survivors.
METHODS: A cross-sectional study of 285 BC survivors was assessed by the Diet History Questionnaire II (DHQ2), a comprehensive food frequency questionnaire, and results converted into Healthy Eating Index 2010 (HEI2010) scores and component macronutrients. Slice-O-Matic software was used to measure subcutaneous adipose tissue (SAT) and visceral adipose tissue (VAT) surface area at L3 by 2 independent readers and converted to adipose indices (divided by height (m2)). To measure inter-rater reliability, 30 cases were read by each reader and a third expert radiologist. Agreement was measured by the intraclass correlation coefficient (ICC) and Bland-Altman plots. Demographic covariates (age, gender, race, income), clinical characteristics (AJCC stage, procedures, Elixhauser comorbidity index), and dietary components were assessed in regression models for their impact on adiposity.
RESULTS: Inter-rater agreement for SAT and VAT was excellent with ICC of 0.94 and 0.96, respectively, further supported by pair-wise Bland-Altman plots. Predictors of increasing SAT included younger age (p[0.01), white race (p<0.01), female gender (p<0.01), and Elixhauser index (p<0.01). Predictors of increasing VAT included white race (p[0.03), male gender (p<0.01), and Elixhauser index(p<0.01). Individually, the daily intake of fat, protein, carbohydrate, and total calories had no effect on body adiposity. However, the composite HEI2010 diet quality score, a composite measure of diet quality, was associated with lower VAT (p<0.001) and SAT (p[0.025) .
CONCLUSIONS: Adiposity predicts poor outcomes and its measurement is highly reliable. The most important predictors of adiposity were non-modifiable: age, gender, race, and comorbidity. Overall diet quality also played a role, though less important, and is modifiable. Nutritional interventions in BC survivors could play a role in improving outcomes.
